Nuron Biotech has secured $80m finance from HealthCare Royalty Partners to support the commercialization and expansion of its Meningitec, a recently acquired vaccine from Pfizer. Meningitec is an established commercial vaccine to prevent ...
Tags: Nuron Biotech, secured finance, vaccine, Meningitec, commercial vaccine